FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214528057> ?p ?o ?g. }

• W4214528057 endingPage "112665" @default.
• W4214528057 startingPage "112665" @default.
• W4214528057 abstract "Gastric cancer is a common gastrointestinal malignancy worldwide, with a high mortality rate and poor prognosis. Esomeprazole (ESO) has been shown to have anticancer activity by affecting cell growth and autophagy and its mechanism in gastric cancer cells is evident. The PI3K/AKT/FOXO3a pathway is central in cancers. 3-Methyladenine (3-MA), a dual inhibitor of PI3K and autophagy, plays a synergistic role in combination with antitumor agents. In this study, we assessed the role of ESO on the PI3K/AKT/FOXO3a pathway and the beneficial effects of ESO combined with 3-MA in gastric cancer cells. Cell viability, proliferation, invasion, migration, apoptosis, autophagy, and protein expression were detected by CCK-8, EdU, Transwell, flow cytometry, immunofluorescence assay, and western blot. ESO decreased cell viability in a concentration- and time-dependent manner and increased autophagy with upregulation of LC3II and P62. Additionally, ESO inhibited the proliferation, migration, and invasion and induced the apoptosis of gastric cancer cells in a concentration-dependent manner. ESO inhibited PI3K/AKT/FOXO3a signaling and EGFR and SKP2 expression concentration-dependent. 3-MA enhanced the antiproliferative activity of ESO and synergistically inhibited PI3K/FOXO3a signaling and the expression of EGFR but not SKP2. Furthermore, pretreatment with the EGFR inhibitor AG1478 enhanced the antiproliferative activity of ESO in gastric cancer cells. In conclusion, our results suggested that the PI3K inhibitor 3-MA promotes the antiproliferative activity of ESO in gastric cancer cells by synergistically downregulating EGFR via the PI3K/FOXO3a pathway." @default.
• W4214528057 created "2022-03-02" @default.
• W4214528057 creator A5007142049 @default.
• W4214528057 creator A5014288187 @default.
• W4214528057 creator A5015072758 @default.
• W4214528057 creator A5029876003 @default.
• W4214528057 creator A5034006751 @default.
• W4214528057 creator A5048931478 @default.
• W4214528057 creator A5060901085 @default.
• W4214528057 date "2022-04-01" @default.
• W4214528057 modified "2023-09-27" @default.
• W4214528057 title "PI3K inhibitor 3-MA promotes the antiproliferative activity of esomeprazole in gastric cancer cells by downregulating EGFR via the PI3K/FOXO3a pathway" @default.
• W4214528057 cites W1963617699 @default.
• W4214528057 cites W1987566410 @default.
• W4214528057 cites W1992477322 @default.
• W4214528057 cites W2011169617 @default.
• W4214528057 cites W2078819305 @default.
• W4214528057 cites W2101096891 @default.
• W4214528057 cites W2113982206 @default.
• W4214528057 cites W2128154461 @default.
• W4214528057 cites W2167708701 @default.
• W4214528057 cites W2273909154 @default.
• W4214528057 cites W2343094253 @default.
• W4214528057 cites W2555600230 @default.
• W4214528057 cites W2767336741 @default.
• W4214528057 cites W2772632346 @default.
• W4214528057 cites W2789911340 @default.
• W4214528057 cites W2804682577 @default.
• W4214528057 cites W2889646458 @default.
• W4214528057 cites W2890156259 @default.
• W4214528057 cites W2902084106 @default.
• W4214528057 cites W2914721738 @default.
• W4214528057 cites W2921841230 @default.
• W4214528057 cites W2923057410 @default.
• W4214528057 cites W2937346106 @default.
• W4214528057 cites W2975634465 @default.
• W4214528057 cites W2988409810 @default.
• W4214528057 cites W2993793724 @default.
• W4214528057 cites W2996264341 @default.
• W4214528057 cites W3000435731 @default.
• W4214528057 cites W3004395575 @default.
• W4214528057 cites W3005857648 @default.
• W4214528057 cites W3008848675 @default.
• W4214528057 cites W3018530191 @default.
• W4214528057 cites W3033366394 @default.
• W4214528057 cites W3071174394 @default.
• W4214528057 cites W3092542424 @default.
• W4214528057 cites W3093056240 @default.
• W4214528057 cites W3094387410 @default.
• W4214528057 cites W3119694432 @default.
• W4214528057 cites W3141987310 @default.
• W4214528057 cites W3151554208 @default.
• W4214528057 cites W3161237247 @default.
• W4214528057 cites W3173982825 @default.
• W4214528057 cites W3195787174 @default.
• W4214528057 doi "https://doi.org/10.1016/j.biopha.2022.112665" @default.
• W4214528057 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35228068" @default.
• W4214528057 hasPublicationYear "2022" @default.
• W4214528057 type Work @default.
• W4214528057 citedByCount "8" @default.
• W4214528057 countsByYear W42145280572022 @default.
• W4214528057 countsByYear W42145280572023 @default.
• W4214528057 crossrefType "journal-article" @default.
• W4214528057 hasAuthorship W4214528057A5007142049 @default.
• W4214528057 hasAuthorship W4214528057A5014288187 @default.
• W4214528057 hasAuthorship W4214528057A5015072758 @default.
• W4214528057 hasAuthorship W4214528057A5029876003 @default.
• W4214528057 hasAuthorship W4214528057A5034006751 @default.
• W4214528057 hasAuthorship W4214528057A5048931478 @default.
• W4214528057 hasAuthorship W4214528057A5060901085 @default.
• W4214528057 hasBestOaLocation W42145280571 @default.
• W4214528057 hasConcept C121608353 @default.
• W4214528057 hasConcept C126322002 @default.
• W4214528057 hasConcept C185592680 @default.
• W4214528057 hasConcept C190283241 @default.
• W4214528057 hasConcept C203522944 @default.
• W4214528057 hasConcept C502942594 @default.
• W4214528057 hasConcept C53227056 @default.
• W4214528057 hasConcept C55493867 @default.
• W4214528057 hasConcept C62112901 @default.
• W4214528057 hasConcept C71924100 @default.
• W4214528057 hasConcept C75217442 @default.
• W4214528057 hasConcept C86554907 @default.
• W4214528057 hasConcept C86803240 @default.
• W4214528057 hasConcept C96232424 @default.
• W4214528057 hasConceptScore W4214528057C121608353 @default.
• W4214528057 hasConceptScore W4214528057C126322002 @default.
• W4214528057 hasConceptScore W4214528057C185592680 @default.
• W4214528057 hasConceptScore W4214528057C190283241 @default.
• W4214528057 hasConceptScore W4214528057C203522944 @default.
• W4214528057 hasConceptScore W4214528057C502942594 @default.
• W4214528057 hasConceptScore W4214528057C53227056 @default.
• W4214528057 hasConceptScore W4214528057C55493867 @default.
• W4214528057 hasConceptScore W4214528057C62112901 @default.
• W4214528057 hasConceptScore W4214528057C71924100 @default.
• W4214528057 hasConceptScore W4214528057C75217442 @default.
• W4214528057 hasConceptScore W4214528057C86554907 @default.
• W4214528057 hasConceptScore W4214528057C86803240 @default.

• next